神经节苷脂治疗新生儿缺氧缺血性脑病的临床观察

Clinical Observation on Gangliosides in Treatment of Hypoxic Ischemic Encephalopathy

目的探析新生儿缺氧缺血性脑病采用神经节苷脂治疗的有效性。方法选择我院近年收治的82例新生儿缺氧缺血性脑病病例作为研究对象,分成观察组与对照组,对照组实施常规治疗,观察组在对照组治疗基础上采用神经节苷脂治疗,对比两组患儿的治疗效果。结果观察组和对照组总有效率分别为92.68%、70.73%,观察组总有效率更高(P<0.05)。结论新生儿缺氧缺血性脑病临床采用神经节苷脂进行治疗,不仅能提高患儿的治疗有效性,还可改善患儿的治疗预后。

Objective To explore newborn hypoxia ischemic encephalopathy with ganglioside effectiveness of treatment. Methods 82 cases of neonatal hypoxic ischemic encephalopathy in recent years as the research object, which were divided into observation group and control group, control group in the implementation of regular treatment, observation group in the control group therapy on the basis of the ganglioside treatment, compared the therapeutic effect of two groups of children. Results The data shows that the observation group and control group total effectiveness was 92.68%, 70.73% respectively, compared with the control group, the observation group total effective rate was higher（P〈0.05）. Conclusion Neonatal hypoxic ischemic encephalopathy clinical uses the ganglioside treatment, not only can improve the therapeutic effectiveness of children, also can obviously improve the patient＇s treatment outcome.